Table 1.
AMH as diagnostic tool for PCOS in various studies
| Study | Type of study | PCOS (N) | Age (years) | AMH cut-off (ng/ml) | Sensitivity (%) | Specificity (%) |
|---|---|---|---|---|---|---|
| Hart et al. (2010) | Prospective cohort | 64 | 14.5–17.6 | 4.20 | 53.1 | 69.8 |
| Lin et al. (2011) | Prospective case–control | 126 | 27.7 ± 5.8 | 7.30 | 76.0 | 70 |
| Dewailly et al. (2011) | Prospective case–control | 62 | 20.1–34.0 | 4.90 | 92 | 97 |
| Eilertsen et al. (2012) | Case–control | 56 | 33.3 ± 5.5 | 2.80 | 94.6 | 97.1 |
| Woo et al. (2012) | Prospective cross section | 87 | 22–38 | 7.82 | 75.9 | 86.8 |
| Homburg et al. (2013) | Prospective case–control | 90 | 32.1 | 6.72 | 60 | 98.2 |
| Wiweko et al. (2014) | Case–control | 71 | 29.55 | 4.45 | 76.1 | 74.6 |
| Present study (2017) | Prospective case–control | 45 | 24.49 ± 3.91 | 3.44 | 77.78 | 68.89 |